2022 Emerging RNA Drug and Smart Manufacturing in Precision Medicine Forum
Published at: 2022-03-07 15:18
Last modified at:2022-03-09 10:11
Event time:
Start at:2022-03-17 16:00
End at:2022-03-17 18:00
2022 Emerging RNA Drug and Smart Manufacturing in Precision Medicine Forum
RNA-based therapeutics are novel medications, serving as next-generation alternatives and offering unique opportunities to treat a broad scope of diseases with a significant success in cancer over the past decade. In addition, from perspectives on pandemic prevention, mRNA vaccines have been developed as well and widely harnessed against COVID-19. Therefore, there is growing interest drawn globally in this new class of therapeutics.

Although development of RNA drugs faces unparalleled challenges, many strategies have been built to improve RNA metabolic stability and intracellular delivery, of which smart manufacturing is the most critical when it comes to clinical development and navigating the regulatory pathways. To expedite the biomedical development with COVID's viral evolution, facilitate networking and in turn co-development between the participants, we are going to have pharmaceutical experts and professionals in this forum sharing the latest trends in this emerging field.

TIME:16:00-18:00 PM, 17th,March 2022 (TW)

09:00-11:00 AM, 17th,March 2022 (CET)

* Powered by Webex or Equivalent with Online Registration Required in Advance

Supervised by

Industrial Development Bureau, MOEA (IDB)

Organized by

Europe-Taiwan Biotech Association (ETBA).

Development Center for Biotechnology (DCB).

Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO)